Table 1 Baseline comparison between control group and diabetic retinopathy patients under initiation of anti-VEGF treatment

Age (SD)

64.4

(± 9.7)

63.5

(± 9.3)

0.7^∆

FAZ area mm²

0.184

(± 0.058)

0.307

(± 0.133)

0.008*

Perimeter mm²

1.753

(± 0.408)

2.415

(± 0.692)

0.002*

Choroid thickness µm

317.8

(± 15.3)

335.9

(± 39.1)

0.07^∆

Choriocapillaris whole image density %

68.4

(± 5.1)

62.6

(± 6.1)

0.003 ^∆

Choriocapillaris foveal area density %

66.3

(± 9.8)

61.2

(± 7.4)

0.014*

Choriocapillaris parafoveal area density %

68.2

(± 4.8)

61.9

(± 6.6)

0.002 ^∆

Retinal whole image density %

50.7

(± 5.6)

46.9

(± 5.1)

0.04 ^∆

Retinal foveal area density %

34.1

(± 6.1)

27.6

(± 5.9)

0.002 ^∆

Retinal parafoveal area density %

53.1

(± 6.0)

49.0

(± 5.6)

0.011*

CST µm

276.6

(± 22.9)

397.1

(± 93.2)

< 0.0001*

Visual acuity ETDRS

81.3

(± 4.6)

69.7

(± 8.1)

< 0.0001*